Coherent Market Insights
Emergence of Covid-19 to Boost Demand for Viral Conjunctivitis Drugs
Viral conjunctivitis can be annoying and painful, but is rarely dangerous. However, if
it persists, it may become painful or cause damage to the eye. It typically appears in
children but can occur in adults. There is no current treatment for viral
conjunctivitis. Most commonly used viral conjunctivitis drugs include, antiviral drugs.
Patients with conjunctivitis often feel redness, warmth and itchiness around the eye.
This is usually caused by inflammation of the eyelids. Redness can spread quickly to
the cheekbones and forehead and may even extend to the neck and scalp. The
intense pain is usually felt on one side only, however, and is not widespread. The
individual may also feel fatigue, loss of appetite and sensitivity to light and noise.
Emergence of Covid-19 has also led to increasing cases of viral conjunctivitis.
Conjunctivitis, nausea or vomiting, and diarrhea are some of the symptoms of novel
coronavirus and included to the list.
In rare instances, viral conjunctivitis can lead to the development of a potentially
life-threatening condition called encephalitis, or an inflammation of the brain and
skull (encephalomatous encephalitis). This is associated with symptoms such as fever
and sometimes seizures. A patient with encephalitis may need urgent treatment
because the infection may spread to the brain and result in a brain tumor. In these
cases, viral conjunctivitis drugs such as antibiotics may be necessary. If the herpes
simplex virus that causes encephalitis is not treated, it can result in death.
While bacterial conjunctivitis often occurs during an acute bout with a particular
virus (such as a common cold), it can also occur sporadically or develop over time.
Acute conjunctivitis can be caused by many different strains of bacteria. Some of
these include, Streptococcus viridans, Staphylococcus aureus and a group of viruses
collectively known as Streptococcal pneumonia. The